Techcyte, Inc.
PrivateLast Round
VC Round
Apr 30, 2026
Total Funding Raised
$34.61M
Momentum
Top 5%
of companies Caplight tracks
Company Overview
Techcyte, Inc. is a healthtech company that provides an AI-powered digital pathology platform for anatomic and clinical pathology.
Sector
Healthcare & Life Sciences
Verticals
Medical AI, Medical Imaging, Healthcare Analytics, Biotechnology, Vertical SaaS
Business Model
B2B
Customer Profile
Subscription SaaS, Usage-Based SaaS
AI Layer
Application
Keywords
Historical Pricing
Historical view of private secondary pricing and transaction trends.
Techcyte, Inc. Comparables
Compare Techcyte, Inc. with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| Proscia | 87% | |
| Deciphex | 84% | |
| AIRA Matrix | 84% |
Techcyte, Inc. Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| VC Round | Apr 30, 2026 | ||||
| VC Round | Jan 11, 2024 | ||||
| Series E | Aug 18, 2021 | ||||
| Seed | Jan 18, 2018 | ||||
| Series A | Jan 18, 2018 | ||||
Seed | Mar 1, 2016 |
Techcyte, Inc. Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| Mayo Clinic Ventures | VC Round |
| Van Tuyl Companies | VC Round |
Market signals
Structured signals derived from secondary market and firmographic data.
- Aug 22, 2026
Monthly visitors increased 45% MoM.
- Jul 20, 2026
Open roles increased to 32, representing 27% of headcount.
Recent news
Latest coverage and updates
- attends_eventSep 8, 2026
Techcyte attended event Strategic Supplier Summit on Sep 8th '26.
- partners_withAug 14, 2026
Techcyte partnered with Elea.ai GmbH on Aug 13th '26.
- launchesJul 15, 2026
Techcyte Inc. launched Anatomic Pathology technology on Jul 15th '26.
- launchesJul 13, 2026
Techcyte Inc. launched Fusion Parasitology Suite at association of Public Health laboratories Conference on Jul 13th '26.
Techcyte, Inc. Filings
Explore SEC and related filing metadata, where available.
| Type | Date | Amount Offered | Amount Sold | Filing | Pages | Download |
|---|
Filing documents are not displayed on this public page. Request access to learn about available coverage.
Request accessFrequently Asked Questions
Common questions about Techcyte, Inc.'s valuation, stock price, and market status.
Is Techcyte, Inc. a public or private company?
Techcyte, Inc. is a private company.
What is the current stock price of Techcyte, Inc.?
Techcyte, Inc. is a private company with no public stock price. No recent secondary market data is available.
How much is Techcyte, Inc. worth (valuation)?
Valuation information for Techcyte, Inc. is not publicly available.
Can I buy Techcyte, Inc. stock?
Techcyte, Inc. shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors. Visit https://www.caplight.com to learn more.
When was Techcyte, Inc.'s last funding round?
Techcyte, Inc.'s most recent funding round was Early Funding on April 30, 2026.
Who are the main investors in Techcyte, Inc.?
Key investors in Techcyte, Inc. include Van Tuyl Companies.
Will Techcyte, Inc. IPO soon?
No public IPO plans have been announced for Techcyte, Inc..
How can I track Techcyte, Inc. secondary market activity?
Caplight tracks bids, offers, and trades for private companies. Visit https://www.caplight.com to monitor Techcyte, Inc.'s secondary market activity and sign up for updates.